- Global Pharma News & Resources

TXOG’s PTSD Focus Group Shows 71% of Patients Achieved PTSD Remission with Medical Cannabis

AUSTIN, Texas--(BUSINESS WIRE)--Texas Original Compassionate Cultivation (TXOG), Texas’ leading medical cannabis provider, today released results from its clinical evaluation of the company’s post-traumatic stress disorder (PTSD) focus group. Focus group participants sampled TXOG’s gummy, lozenge and tincture products at various dosages based on individual prescriptions from their physicians.

Following the focus group’s completion, TXOG released survey results in which patients reported quick onset of the products’ medicinal effects and unanimous relief from their PTSD symptoms. In addition to the survey, Dr. Matthew Brimberry, a board-certified family medicine physician, the head of Texas Cannabis Clinic and the focus group’s presiding physician, evaluated the group using an entrance and exit PCL-5 questionnaire, a 20-item self-reporting measure that assesses the 20 clinical symptoms of PTSD listed in the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders (DSM-5).

Dr. Brimberry’s assessment noted the medicine was well tolerated and no patient discontinued treatment due to medicinal side effects. Key findings from the assessment also included:

  • Overall PTSD symptoms in the focus group were reduced 47% from an initial PCL-5 mean score of 54.3 to 28.6 after 90 days.
  • 93% of patients experienced decreased symptom severity, while 86% of the group showed a clinically significant reduction in PTSD symptoms.
  • At the end of the 90-day focus group, 71% of the group achieved PTSD remission—defined as a PCL-5 score of less than 33—while using TXOG’s product.

“My team and I have served hundreds of Texans suffering from PTSD, cancer and other debilitating conditions. Introducing medical cannabis into their treatment plans has been truly life-changing,” said Dr. Brimberry. “As a physician, my goal is to alleviate a patient’s symptoms to the best of my ability, improve their quality of life and better their long-term prognosis. To observe the participants of TXOG’s PTSD focus group experience such a dramatic, positive change in their symptoms has been extraordinary and conclusively demonstrates the impact medical cannabis can have in treatment.”

The focus group—composed exclusively of veterans clinically diagnosed with PTSD under the DSM-5’s trauma- and stressor-related disorders—evaluated symptom response, patient product preference and medical cannabis’ potential to reduce traditional pharmaceutical consumption. Participants reported a reduction in pain, decreased nightmares, better sleep and improved mood while using TXOG’s medical cannabis products.

“Every day, we hear another incredible story of a patient who has reclaimed their life through the power of medical cannabis,” said Morris Denton, CEO of TXOG. “Dr. Brimberry’s clinical analysis reinforces the medical efficacy of our products, demonstrates Texas Original’s dedication to product testing and patient feedback, and showcases how veterans experiencing PTSD—as well as other patients throughout Texas living with similar symptoms—can benefit from a medical cannabis prescription.”

“This observational study echoes what veterans have been telling us. Medicinal cannabis should be considered as one of the first-line treatment options for PTSD. We are seeing significantly better results with cannabis when compared to conventional pharmacotherapy,” Dr. Brimberry added.

TXOG’s gummy, tincture and lozenge products are available for statewide delivery, for pickup at TXOG’s dispensary in Austin, Texas, and through the company’s convenient pick-up locations in North Austin, Addison, Dallas, El Paso, Fort Worth, Houston, Lubbock, San Antonio and Wichita Falls. To learn whether you or a loved one qualifies for medical cannabis, visit

About Texas Original Compassionate Cultivation

Texas Original Compassionate Cultivation (TXOG) is the leading licensed medical marijuana producer in Texas, working alongside physicians to provide the highest quality cannabis medicine to patients and families seeking relief across the state. As fellow Texans, we are dedicated to representing the integrity of this great state with our commitment to quality, consistency and purity in every product we produce. We remain committed to advancing safe, legal access to this powerful medicine. TXOG is headquartered in Austin, with delivery throughout the entire state. For more information, visit


Emma Chase

Editor Details

  • Company:
    • Businesswire
Last Updated: 08-Mar-2022